Oppenheimer & CO Inc Catabasis Pharmaceuticals, Inc. Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 12, 2021	SELL	N/A	-61,500 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	N/A	-5,500 Reduced 8.21%	61,500 $130,000
Q1 2021 May 10, 2021	SELL	N/A	-3,200 Reduced 4.56%	67,000 $194,000
Q4 2020 Feb 11, 2021	SELL	N/A	-35,521 Reduced 33.6%	70,200 $150,000
Q3 2020 Nov 13, 2020	SELL	N/A	-1,740 Reduced 1.62%	105,721 $654,000
Q2 2020 Aug 11, 2020	SELL	N/A	-719 Reduced 0.66%	107,461 $691,000
Q1 2020 May 08, 2020	BUY	N/A	29,931 Added 38.25%	108,180 $449,000
Q4 2019 Feb 07, 2020	SELL	N/A	-1,600 Reduced 2.0%	78,249 $462,000
Q3 2019 Oct 31, 2019	BUY	N/A	11,143 Added 16.22%	79,849 $431,000
Q2 2019 Aug 09, 2019	SELL	N/A	-23,178 Reduced 25.23%	68,706 $554,000
Q1 2019 Apr 24, 2019	BUY	N/A	45,303 Added 97.26%	91,884 $727,000
Q4 2018 Jan 29, 2019	BUY	N/A	46,581 New	46,581 $203,000

About Catabasis Pharmaceuticals, Inc.

Ticker CATB
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,948,800
Market Cap $657M

More about CATB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.